检验医学与临床
檢驗醫學與臨床
검험의학여림상
Laboratory Medicine and Clinic
2015年
23期
3451-3452,3455
,共3页
李刚%陈振萍%唐凌%甄英姿%吴心怡%吴润晖
李剛%陳振萍%唐凌%甄英姿%吳心怡%吳潤暉
리강%진진평%당릉%견영자%오심이%오윤휘
血友病%儿童%凝血因子 Ⅷ%抑制物%活化部分凝血活酶时间
血友病%兒童%凝血因子 Ⅷ%抑製物%活化部分凝血活酶時間
혈우병%인동%응혈인자 Ⅷ%억제물%활화부분응혈활매시간
hemophilia%children%F Ⅷ%inhibitor%APTT
目的:通过受试者工作特征曲线(ROC 曲线)分析,确定利用即刻法与孵育后活化部分凝血活酶时间(APTT )结果差值预测血友病 A 凝血因子Ⅷ抑制物产生的临界诊断点。方法回顾分析172例血友病 A 患儿的APTT 纠正试验及抑制物定量监测结果,并应用 ROC 曲线分析血友病 A 凝血因子Ⅷ抑制物阳性的最佳临界点。结果 ROC 曲线下面积=0.908(95% CI :0.875~0.941,P <0.05),Youden 值为0.679,所对应的 APTT 差值为2.6 s ,为有无抑制物的最佳诊断界点。此时敏感度为80.4%,诊断特异度为87.5%。结论2.6 s 的 APTT 纠正试验秒值差可作为儿童血友病 A 凝血因子Ⅷ抑制物产生的早期筛查指标。
目的:通過受試者工作特徵麯線(ROC 麯線)分析,確定利用即刻法與孵育後活化部分凝血活酶時間(APTT )結果差值預測血友病 A 凝血因子Ⅷ抑製物產生的臨界診斷點。方法迴顧分析172例血友病 A 患兒的APTT 糾正試驗及抑製物定量鑑測結果,併應用 ROC 麯線分析血友病 A 凝血因子Ⅷ抑製物暘性的最佳臨界點。結果 ROC 麯線下麵積=0.908(95% CI :0.875~0.941,P <0.05),Youden 值為0.679,所對應的 APTT 差值為2.6 s ,為有無抑製物的最佳診斷界點。此時敏感度為80.4%,診斷特異度為87.5%。結論2.6 s 的 APTT 糾正試驗秒值差可作為兒童血友病 A 凝血因子Ⅷ抑製物產生的早期篩查指標。
목적:통과수시자공작특정곡선(ROC 곡선)분석,학정이용즉각법여부육후활화부분응혈활매시간(APTT )결과차치예측혈우병 A 응혈인자Ⅷ억제물산생적림계진단점。방법회고분석172례혈우병 A 환인적APTT 규정시험급억제물정량감측결과,병응용 ROC 곡선분석혈우병 A 응혈인자Ⅷ억제물양성적최가림계점。결과 ROC 곡선하면적=0.908(95% CI :0.875~0.941,P <0.05),Youden 치위0.679,소대응적 APTT 차치위2.6 s ,위유무억제물적최가진단계점。차시민감도위80.4%,진단특이도위87.5%。결론2.6 s 적 APTT 규정시험초치차가작위인동혈우병 A 응혈인자Ⅷ억제물산생적조기사사지표。
Objective To predict the critical diagnosis point of F Ⅷ inhibitor through determining the differ‐ence between immediate and incubated APTT results by ROC curve analysis .Methods To retrospectively analyze the quantitative results of APTT correction and F Ⅷ inhibitor experiment in 172 cases of HA children .And to analyze the best of critical positive point of F Ⅷ inhibitor by ROC curve .Results The area under the ROC curve (AUC) was 0 .908(95% CI :0 .875 - 0 .941 ,P< 0 .05) and Youden value was 0 .679 .The corresponding difference of APT T (2 .6 s) was the best diagnostic cutoff point for predicting F Ⅷ inhibitors .The sensitivity was 80 .4% and the specificity was 87 .5% for predicting F Ⅷ inhibitors .Conclusion The time difference (2 .6 s) of APTT correcting test can pro‐vide a reference and predictive indicator for early diagnosis of F Ⅷ inhibitor development in children with HA .